Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis
Study sponsor: Aclaris Therapeutics, Inc. · ACRS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-10-26Actual
Enrollment · participants250Actual
Source updated2024-10-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.